FMR LLC 13D and 13G filings for Ionis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:16 am Purchase | 2024-02-08 | 13G | Ionis Pharmaceuticals, Inc. IONS | FMR LLC | 21,520,872 15.000% | 213,353 (+1.00%) | Filing |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | Ionis Pharmaceuticals, Inc. IONS | FMR LLC | 21,307,519 14.999% | 126,017 (+0.59%) | Filing |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | Ionis Pharmaceuticals, Inc. IONS | FMR LLC | 21,181,502 14.999% | 201,780 (+0.96%) | Filing |
| 2021-02-08 10:25 am Sale | 2021-02-05 | 13G | Ionis Pharmaceuticals, Inc. IONS | FMR LLC | 20,979,722 14.999% | -144,340 (-0.68%) | Filing |